At the molecular level, monensin has pleiotropic effects affecting multiple cancer-related pathways such as the E2F/DP1, STAT1/2, NFκB, AP-1, Wnt, and Elk-1/SRF pathways, likely dependent on the cellular model [77]. This evidence concerns the gene STAT1 and cancer.